Drawing for LIPOZA

USPTO serial 98658353

LIPOZA

Reviewed by CopyMark Law Group

Status 973
Filing date
Status date
Registration date
—
Examiner
DIGAN, MATTHEW M
Law office
GENERIC WEB UPDATE

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with LIPOZA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Renuka Rajan

Renuka Rajan Rajan IPIndira Gandhi St, K K NagarPlot No. 431, First FloorTrichy, TN, 620021

Goods and services

ClassDescriptionStatusFirst use
001Active chemical ingredients for use in the manufacture of pharmaceuticals for treating general health conditions; Antioxidants for use in the manufacture of pharmaceuticals; Biometallic compounds for use in the manufacture of pharmaceutical preparations; Carbohydrates used as an ingredient in the manufacture of nutraceuticals; Chemical additives for use in the manufacture of pharmaceuticals; Chemical additives for use in the manufacture of food, pharmaceuticals, cosmetics; Chemically activated adhesive label for sensing the presence of oxygen in intravenous medical and pharmaceutical containers; Date seed oil for use in the manufacture of cosmetics, pharmaceutical preparations, veterinary preparations; Dendrimer-based polymers for use in the manufacture of capsules for pharmaceuticals; Emollient used as an ingredient in the manufacture of cosmetics, toiletries, and pharmaceuticals; Enzymes for use in the manufacture of nutraceuticals; Excipients for use in the manufacture of use in the manufacture of pharmaceuticals, cosmetics; Perfluorinated chemical compounds prepared synthetically for use in the manufacture of cosmetics and pharmaceuticals; Plant extracts, other than essential oils, for use in the manufacture of pharmaceuticals; Polymers and polymeric additives for use in the manufacture of pharmaceutical preparations, medical devices, plastics, cosmetics, personal care products, coatings, adhesives, and lubricants; Polymers and polymeric additives for use in the manufacture of pharmaceutical preparations, plastics, cosmetics, personal care products, coatings, adhesives, and lubricants; Polyvinyl alcohol soluble films for use in the manufacture of delivery agents for pharmaceuticals, breath freshener, vitamins, and candy; Reagents for testing the sterility of pharmaceuticals and injectable solutions; Sodium hyaluronate for use in the manufacture of pharmaceuticals, cosmetics; Tea extracts for use in the manufacture of pharmaceuticals; Vitamins for manufacturing use; Vitamins for use in the manufacture of pharmaceuticalsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 4, 2026TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Aug 4, 2026ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 4, 2026REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 13, 2026KSNRNOTICE OF SUSPENSION EMAILED - PENDING SCO—
Jul 13, 2026KSCOSHOW CAUSE ORDER—
Mar 16, 2026KSNSNOTICE OF SUSPENSION EMAILED - ADMIN REVIEW—
Mar 16, 2026KSADSUSPENDED PENDING ADMINISTRATIVE REVIEW—
Oct 11, 2025EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Apr 15, 2025NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Feb 18, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 18, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 12, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 29, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 29, 2025DOCKASSIGNED TO EXAMINER—
Jan 15, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 20, 2024NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance